ALAlfredo Vivas Lopez

Alfredo Vivas Lopez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alfredo Vivas Lopez has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Preliminary Safety Evaluation of the Bendos Q Powered Stapling System in Laparoscopic Sleeve Gastrectomy

    by Sofía Lorenzo Mañas, Sofía Lorenzo, Rafael Restrepo Núñez, Rafael Restrepo, Kléber Falcón Bonilla, Amaia González Rivas, Javier Goncalves Morales, Alfredo Vivas López, Alfredo Vivas

    Mañas SL, et al. J Metab Bariatr Surg. 2026 Aug;15(2):113-120. https://doi.org/10.17476/jmbs.2026.15.2.113

  • Open Access

    Low anterior resection with transanal transection and single-stapled anastomosis: technical aspects and initial results

    by Alfredo Vivas López, Oscar Garcia Villar, Javier Garcia Borda, Rafael Restrepo Nuñez, Eduardo Rubio, Cristina Nevado, Pablo Pelaez, Maria Labalde Martinez, David Alias, Kleber Falcon, et al.

    Background: Rectal cancer (RC) is a surgical challenge due to its technical complexity. The double-stapled (DS) technique, a standard for colorectal anastomosis, has been associated with notable drawbacks, including a high incidence of anastomotic leak (AL). Low anterior resection with transanal transection and single-stapled (TTSS) anastomosis has emerged to mitigate those drawbacks. Methods: Observational study in which it described the technical aspects and results of the initial group of patients with medium-low RC undergoing elective laparoscopic total mesorectal excision (TME) and TTSS. Results: Twenty-two patients were included in the series. Favourable postoperative outcomes with a median length of stay of 5 days and an AL incidence of 9.1%. Importantly, all patients achieved complete mesorectal excision with tumour-free margins, and no mortalities were reported. Conclusion: TTSS emerges as a promising alternative for patients with middle and lower rectal tumours, offering potential benefits in terms of morbidity reduction and oncological integrity compared with other techniques.


  • Open Access

    Quality Indicators of Transanal Total Mesorectal Excision (TaTME) for Rectal Cancer

    by María Labalde Martínez, Alfredo Vivas Lopez, Juan Ocaña Jimenez, Cristina Nevado García, Oscar García Villar, Eduardo Rubio Gonzalez, Francisco Javier García Borda, Felipe Cruz Vigo, Eduardo Ferrero Herrero

    Introduction Transanal total mesorectal excision (TaTME) has revolutionized the surgical techniques for lower-third rectal cancer. The aim of the present study was to analyze the outcomes of quality indicators of TaTME for rectal cancer compared with laparoscopic TME (LaTME). Methods A cohort prospective study with 50 (14 female and 36 male) patients, with a mean age of 67 (range: 55.75 to 75.25) years, who underwent surgery for rectal cancer. In total, 20 patients underwent TaTME, and 30, LaTME. Every TaTME procedure was performed by experienced colorectal surgeons. The sample was divided into two groups (TaTME and LaTME), and the quality indicators of the surgery for rectal cancer were analyzed. Results There were no statistically significant differences regarding the patients and the main characteristics of the tumor (age, gender, American Society of Anesthesiologists [ASA] score, body mass index [BMI], tumoral stage, neoadjuvant therapy, and distance from the tumor to the external anal margin) between the two groups. The rates of: postoperative morbidity (TaTME: 35%; LaTME: 30%; p = 0.763); mortality (0%); anastomotic leak (TaTME: 10%; LaTME: 13%; p = 0.722); wound infection (TaTME: 0%; LaTME: 3.3%; p = 0.409); reoperation (TaTME: 5%; LaTME: 6.6%; p = 0.808); and readmission (TaTME: 5%; LaTME: 0%; p = 0.400), as well as the length of the hospital stay (TaTME: 13.5 days; LaTME: 11 days; p = 0.538), were similar in both groups. There were no statistically significant differences in the rates of positive circumferential resection margin (TaTME: 5%; LaTME: 3.3%; p = 0.989) and positive distal resection margin (TaTME: 0%; LaTME: 3.3%; p = 0.400), the completeness of the TME (TaTME: 100%; LaTME: 100%), and the number of lymph nodes harvested (TaTME: 15; LaTME: 15.5; p = 0.882) between two groups. Conclusion Transanal total mesorectal excision is a safe and feasible surgical procedure for middle/lower-third rectal cancer.

  • Open Access

    Impact of the Covid-19 Pandemic on Colorectal Cancer Surgery in Madrid

    by Maria Labalde Martínez, Francisco Javier García Borda, Cristina Narvaez Chavez, Alfredo Vivas Lopez, Oscar García Villar, Ramón Gomez, Rafael Ramos Martinez, Felipe de La Cruz Vigo, Eduardo Ferrero Herrero

    Introduction The Covid-19 pandemic has had an important impact on colorectal cancer surgery, for hospital resources had to be redistributed in favour of Covid-19 patients. The aim of the present study is to analyze our results in colorectal oncologic surgery during the Covid-19 pandemic in patients with and without perioperative SARS-CoV-2 infection. Methods In total, 32 patients (19 male and 13 female patients), with a mean age of 64 years (range: 57.2 to 69.5 years) with colorectal cancer underwent surgery under the recommendations of surgical societies included in a protocol. Data collection included clinical characteristics (gender, age, body mass index, American Society of Anesthesiologists score, tumor location, preoperative staging, lymphopenia), data related to SARS-CoV-2 infection (postoperative symptoms, diagnostic tests), operative details (surgical procedure, approach, duration, stoma), pathological outcomes (tumor stage, number of lymph nodes harvested, distal and circumferential radial margins, quality of the total mesorectal excision), and surgical outcomes (morbidity, mortality, hospital stay, and the rates of reoperation and readmission). Results A total of 3 (9.4%) patients who underwent colorectal surgery during the Covid-19 pandemic were infected by SARS-CoV-2 in the postoperative period. Chronic obstructive pulmonary disease was associated with Covid-19 (6.2% versus 33.3%; p = 0.042), and surgical morbidity was higher among Covid-19 patients (100% versus 37.9%; p = 0.039). There were not significant differences between COVID-19 patients and non-COVID-19 patients in relation to the rest of the analyzed outcomes. Conclusion During the Covid-19 pandemic, colorectal cancer surgery should be performed according to the recommendations of surgical societies. However, Covid-19 patients could present a higher morbidity rate.

  • Step‐by‐step right colectomy and intracorporeal stapled side‐to‐side ileocolic anastomosis – a video vignette

    by J. Ocaña, M. Labalde‐Martinez, A. Vivas, L. González, P. Pelaez, J. García‐Borda, E. Ferrero

    Click on the article title to read more.

  • Laparoscopic sigmoid resection for a giant colonic diverticulum – a video vignette

    by Juan Ocaña, Alfredo Vivas, María Labalde, Pablo Pelaez, Sandra García, Javier García‐Borda, Eduardo Ferrero

    A Giant Colonic Diverticulum (GCD) is a rare manifestiation of colonic diverticular disease. It is more often located in the sigmoid colon. It is defined by a colonic diverticulum greater than 4cm in diameter (medium size 4‐9cm). It is usually located at the anti‐mesenteric border of the sigmoid colon. It was first described in 1946, although less than 200 cases are reported in the literature, mostly as case reports. While GCD pathophysiology remains unclear, the “Ball‐valve” theory is the most accepted. GCD should be managed with surgical excision. If it presents as acute diverticulitis, it should be treated according to clinical guidelines.